BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7803067)

  • 21. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia?
    Hislop TG; Clarke HF; Deschamps M; Joseph R; Band PR; Smith J; Le N; Atleo R
    Can Fam Physician; 1996 Sep; 42():1701-8. PubMed ID: 8828873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of self-reported breast and cervical cancer screening tests among low-income minority women.
    Paskett ED; Tatum CM; Mack DW; Hoen H; Case LD; Velez R
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):721-6. PubMed ID: 8877064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health.
    Blackwell DL; Martinez ME; Gentleman JF
    Womens Health Issues; 2008; 18(2):85-99. PubMed ID: 18182305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodology for reorganization of the cervical cancer program in Chile.
    Salas I
    Cancer Detect Prev; 2006; 30(1):38-43. PubMed ID: 16504420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Pap test by a population group in Buenos Aires.
    Klimovsky E; Matos E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pressing the key pad: trial of a novel approach to health promotion advice.
    Corkrey R; Parkinson L; Bates L
    Prev Med; 2005 Aug; 41(2):657-66. PubMed ID: 15917066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
    Koval AE; Riganti AA; Foley KL
    N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utilization of Pap test services of women: a nationwide study in Taiwan.
    Lee FH; Wang HH
    Cancer Nurs; 2011; 34(6):464-9. PubMed ID: 21372700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pap smear tests in general practice. An update.
    Ward J; Sanson-Fisher R
    Aust Fam Physician; 1992 Apr; 21(4):465-6. PubMed ID: 1530474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community screening for cervical cancer in New Hampshire.
    Dietrich AJ; Carney-Gersten P; Holmes DW; McIntyre OR; Reed S; Clauson B; Zaso K
    J Fam Pract; 1989 Sep; 29(3):319, 321, 323. PubMed ID: 2769198
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer.
    Norman SA; Talbott EO; Kuller LH; Stolley PD; Dunn MS; Baffone K; Klionsky B; Weinberg GB
    Arch Intern Med; 1991 Jan; 151(1):58-64. PubMed ID: 1985610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can mobile units improve the strategies for cervical cancer prevention?
    Mauad EC; Nicolau SM; Gomes UA; da Costa Vieira RA; de Castro Mattos JS; Longatto-Filho A; Baracat EC
    Diagn Cytopathol; 2010 Oct; 38(10):727-30. PubMed ID: 20014304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening HMO women overdue for both mammograms and pap tests.
    Valanis BG; Glasgow RE; Mullooly J; Vogt TM; Whitlock EP; Boles SM; Smith KS; Kimes TM
    Prev Med; 2002 Jan; 34(1):40-50. PubMed ID: 11749095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for cervical cancer by general practitioners in Ghent, Belgium.
    De Schryver A; Derese A; Geldhof A; Vuylsteek K
    Cancer Detect Prev; 1989; 13(5-6):343-8. PubMed ID: 2743357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes from a mass media campaign to promote cervical screening in NSW, Australia.
    Morrell S; Perez DA; Hardy M; Cotter T; Bishop JF
    J Epidemiol Community Health; 2010 Sep; 64(9):777-83. PubMed ID: 19822553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vicious cycle of inadequate early detection: a complementary study on barriers to cervical cancer screening among middle-aged and older women.
    Leach CR; Schoenberg NE
    Prev Chronic Dis; 2007 Oct; 4(4):A95. PubMed ID: 17875270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pap smear screening intervals among patients with cervical cancer in West Virginia.
    Jubelirer S; Baron R; Mairs D
    Prog Clin Biol Res; 1989; 293():323-30. PubMed ID: 2726944
    [No Abstract]   [Full Text] [Related]  

  • 40. [Participation of women in cervical cancer screening].
    Kallio M; Kauraniemi T; Nousiainen AR; Hanstén S; Rytsölä J; Heikkilä M; Hakama M
    Duodecim; 1994; 110(11):1061-7. PubMed ID: 7588113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.